Tidhi Innovation Inc.

This study is testing if a medication called guselkumab can help people with Crohn's disease or ulcerative colitis who still have active symptoms despite taking ustekinumab. About 200 adults in Canada will switch to guselkumab and be monitored for one year to see if their symptom…